669 related articles for article (PubMed ID: 7889211)
21. Comparative effects of candesartan and enalapril on augmented vasoconstrictive responses to endothelin-1 in coronary vessels of spontaneously hypertensive rats.
Miki S; Takeda K; Hatta T; Harada S; Kido H; Oguni A; Moriguchi J; Morimoto S; Kawa T; Sasaki S; Nakagawa M
Am J Hypertens; 2002 Mar; 15(3):286-90. PubMed ID: 11939622
[TBL] [Abstract][Full Text] [Related]
22. Improvement in baroreflex function by an oral angiotensin receptor antagonist in rats with myocardial infarction.
Nishizawa M; Kumagai H; Ichikawa M; Oshima N; Suzuki H; Saruta T
Hypertension; 1997 Jan; 29(1 Pt 2):458-63. PubMed ID: 9039142
[TBL] [Abstract][Full Text] [Related]
23. AT1 receptor antagonist combats oxidative stress and restores nitric oxide signaling in the SHR.
Welch WJ; Wilcox CS
Kidney Int; 2001 Apr; 59(4):1257-63. PubMed ID: 11260386
[TBL] [Abstract][Full Text] [Related]
24. Antihypertensive therapy augments endothelium-dependent relaxations in coronary arteries of spontaneously hypertensive rats.
Tschudi MR; Criscione L; Novosel D; Pfeiffer K; Lüscher TF
Circulation; 1994 May; 89(5):2212-8. PubMed ID: 8181147
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin II type 1 receptor blocker prevents atrial structural remodeling in rats with hypertension induced by chronic nitric oxide inhibition.
Okazaki H; Minamino T; Tsukamoto O; Kim J; Okada K; Myoishi M; Wakeno M; Takashima S; Mochizuki N; Kitakaze M
Hypertens Res; 2006 Apr; 29(4):277-84. PubMed ID: 16778335
[TBL] [Abstract][Full Text] [Related]
26. Persistent cardiovascular effects of chronic renin-angiotensin system inhibition following withdrawal in adult spontaneously hypertensive rats.
Paull JR; Widdop RE
J Hypertens; 2001 Aug; 19(8):1393-402. PubMed ID: 11518847
[TBL] [Abstract][Full Text] [Related]
27. Positive influence of AT(1) receptor antagonism upon the impaired celiprolol-induced vasodilatation in aorta from spontaneously hypertensive rats.
Sauvaget F; Mallem MY; Bucas V; Gogny M; Desfontis JC; Noireaud J
Eur J Pharmacol; 2010 Oct; 644(1-3):169-75. PubMed ID: 20637193
[TBL] [Abstract][Full Text] [Related]
28. Treatment with the arginase inhibitor N(omega)-hydroxy-nor-L-arginine improves vascular function and lowers blood pressure in adult spontaneously hypertensive rat.
Bagnost T; Berthelot A; Bouhaddi M; Laurant P; André C; Guillaume Y; Demougeot C
J Hypertens; 2008 Jun; 26(6):1110-8. PubMed ID: 18475148
[TBL] [Abstract][Full Text] [Related]
29. Developmental activity of the renin-angiotensin system during the "critical period" modulates later L-NAME-induced hypertension and renal injury.
Ishiguro K; Sasamura H; Sakamaki Y; Itoh H; Saruta T
Hypertens Res; 2007 Jan; 30(1):63-75. PubMed ID: 17460373
[TBL] [Abstract][Full Text] [Related]
30. Reduced basal NO-mediated dilation and decreased endothelial NO-synthase expression in coronary vessels of spontaneously hypertensive rats.
Crabos M; Coste P; Paccalin M; Tariosse L; Daret D; Besse P; Bonoron-Adele S
J Mol Cell Cardiol; 1997 Jan; 29(1):55-65. PubMed ID: 9040021
[TBL] [Abstract][Full Text] [Related]
31. AT1 receptor antagonist, TCV 116, does not prevent cardiac hypertrophy in salt-loaded Dahl salt-sensitive rats.
Sugimoto K; Gotoh E; Takasaki I; Ebina T; Iwamoto T; Takizawa T; Shionoiri H; Ishii M
Clin Exp Pharmacol Physiol; 1996 Apr; 23(4):282-6. PubMed ID: 8717062
[TBL] [Abstract][Full Text] [Related]
32. Effects of the angiotensin II receptor antagonist, TCV-116, on blood pressure and the renin-angiotensin system in healthy subjects.
Ogihara T; Nagano M; Mikami H; Higaki J; Kohara K; Azuma J; Aoki T; Hamanaka Y
Clin Ther; 1994; 16(1):74-86. PubMed ID: 8205603
[TBL] [Abstract][Full Text] [Related]
33. Protective effects of candesartan cilexetil (TCV-116) against stroke, kidney dysfunction and cardiac hypertrophy in stroke-prone spontaneously hypertensive rats.
Inada Y; Wada T; Ojima M; Sanada T; Shibouta Y; Kanagawa R; Ishimura Y; Fujisawa Y; Nishikawa K
Clin Exp Hypertens; 1997 Oct; 19(7):1079-99. PubMed ID: 9310205
[TBL] [Abstract][Full Text] [Related]
34. Defective nitric oxide production impairs angiotensin II-induced Na-K-ATPase regulation in spontaneously hypertensive rats.
Javkhedkar AA; Lokhandwala MF; Banday AA
Am J Physiol Renal Physiol; 2012 Jan; 302(1):F47-51. PubMed ID: 21900450
[TBL] [Abstract][Full Text] [Related]
35. Effect of dual angiotensin converting enzyme/neutral endopeptidase inhibition, angiotensin converting enzyme inhibition, or AT1 antagonism on coronary microvasculature in spontaneously hypertensive rats.
Pu Q; Larouche I; Schiffrin EL
Am J Hypertens; 2003 Nov; 16(11 Pt 1):931-7. PubMed ID: 14573331
[TBL] [Abstract][Full Text] [Related]
36. Modulation of endothelin-1 coronary vasoconstriction in spontaneously hypertensive rats by the nitric oxide system.
Miki S; Takeda K; Kiyama M; Hatta T; Moriguchi J; Kawa T; Morimoto S; Nakamura K; Itoh H; Nakata T; Sasaki S; Nakagawa M
Am J Hypertens; 2000 Jan; 13(1 Pt 1):83-7. PubMed ID: 10678275
[TBL] [Abstract][Full Text] [Related]
37. Renal protective effect of TCV-116 in stroke-prone spontaneously hypertensive rats.
Kim S; Ohta K; Hamaguchi A; Omura T; Yukimura T; Miura K; Inada Y; Wada T; Ishimura Y; Chatani F
Blood Press Suppl; 1994; 5():54-6. PubMed ID: 7889201
[TBL] [Abstract][Full Text] [Related]
38. Regression of left ventricular hypertrophy prevents ischemia-induced lethal arrhythmias. Beneficial effect of angiotensin II blockade.
Kohya T; Yokoshiki H; Tohse N; Kanno M; Nakaya H; Saito H; Kitabatake A
Circ Res; 1995 May; 76(5):892-9. PubMed ID: 7729007
[TBL] [Abstract][Full Text] [Related]
39. Differential effect of chronic inhibition of calcium channel and angiotensin II type 1-receptor on aldosterone synthesis in spontaneously hypertensive rats.
Otsuka F; Ogura T; Kataoka H; Kishida M; Takahashi M; Mimura Y; Yamauchi T; Makino H
J Steroid Biochem Mol Biol; 2000 Oct; 74(3):125-36. PubMed ID: 11086231
[TBL] [Abstract][Full Text] [Related]
40. Normalization of endothelial and inducible nitric oxide synthase expression in brain microvessels of spontaneously hypertensive rats by angiotensin II AT1 receptor inhibition.
Yamakawa H; Jezova M; Ando H; Saavedra JM
J Cereb Blood Flow Metab; 2003 Mar; 23(3):371-80. PubMed ID: 12621312
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
